Olatuton 10 mg powder and solvent for prolonged-release suspension for injection

Licence status
Authorised: 19/08/2019
Active substances
Octreotide
Dosage Form
Powder and solvent for prolonged-release suspension for injection
Licence number
PA1986/076/001
Licence holder
Teva B.V.

Product documents

Licence information

ATC code
H01CB Somatostatin and analogues, H01CB02 octreotide
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
19/08/2019